Skip to main content
. 2024 May 10;26:98. doi: 10.1186/s13075-024-03331-8

Table 5.

League table of BICLA stable response of targeted small-molecule drug therapy

RR(95%CI)
Baricitinib Deucravacitinib Fenebrutinib Placebo
Baricitinib 0
Deucravacitinib 0.68 (0.52, 0.91) 0
Fenebrutinib 0.92 (0.69, 1.21) 1.35 (0.92, 1.95) 0
Placebo 1.06 (0.97, 1.16) 1.56 (1.19, 2.04) 1.16 (0.89, 1.52) 0